ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 11396 recruiting trials
REACT-01: Reversing Autoimmunity Through Cell Therapy
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation
RecruitingNCT06312644 ↗
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
👨⚕️ Sydney Williams, North American Coordinating Center (NACC)📍 8 sites📅 Started Dec 2024View details ↗
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia
Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
RecruitingNCT06709833 ↗
Meningioma and Embolism Thrombosis Risk & Investigation of Coagulation
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingNCT06832839 ↗
Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
Pulmonary Functions in Sickle Cell Disease: Response to Acu-TENS
Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis
🏥 The Children's Hospital of Zhejiang University School of Medicine📍 2 sites📅 Started Dec 2024View details ↗
RecruitingNCT06274788 ↗
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
RecruitingNCT06817434 ↗
Study on Evaluating the Effectiveness of Statins in the Treatment of Moyamoya Disease
Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →